Juha Peltonen

Dr. Juha Peltonen


Research Focus & Metrics

Academic Career Length

47Years (1980-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 June 2016 in Journal of Clinical Oncology
Verified
Journal Article
Closed access
EUElina Uusitalo
Elina Uusitalo
MRMatti Rantanen
Matti Rantanen
RKRoope A. Kallionpää
Roope A. Kallionpää
MPMinna Pöyhönen
Minna Pöyhönen
JLJussi Leppävirta
Jussi Leppävirta
JPJuha Peltonen
Juha Peltonen
Purpose: The current study was designed to determine the risk of cancer in patients with neurofibromatosis type 1 (NF1) by cancer type, age, and sex with unprecedented accuracy to be achieved by combining two total population–based registers.Patients and Methods: A population-based series of patients with NF1 (N = 1,404; 19,076 person-years) was linked to incident cancers recorded in the Finnish Cancer Registry and deaths recorded in the national Population Register Centre between 1987 and 2012. Standardized incidence ratios (SIRs) and standardized mortality ratios (SMRs) were calculated for selected cancer types. Survival of the patients with cancer with and without NF1 was compared.Results: In malignant peripheral nerve sheath tumors and CNS tumors, the cancers traditionally associated with NF1, we observed SIRs of 2,056 (95% CI, 1,561 to 2,658), and 37.5 (95% CI, 30.2 to 46.0), respectively, and SMRs of 2,301 (95% CI, 1,652 to 3,122) and 30.2 (95% CI, 19.1 to 45.2), respectively. We found an unequivocally increased risk for breast cancer. In particular, SIR was 11.1 (95% CI, 5.56 to 19.5) for breast cancer in women with NF1 age < 40 years; the overall SMR for breast cancer was 5.20 (95% CI, 2.38 to 9.88). Particularly high overall SIRs were observed in patients with NF1 age < 15 years: women, 87.6 (95% CI, 58.6 to 125); men, 45.6 (95% CI, 28.4 to 68.5). An estimated lifetime cancer risk for patients with NF1 was 59.6%. The 5-year survival of patients with cancer and NF1, excluding nervous tissue cancers, was worse than that of comparable patients with cancers without NF1 (54.0% v 67.5%; P = .01).Conclusion: Our results emphasize the general cancer proclivity of patients with NF1. These findings should translate to clinical practices to determine clinical interventions and focused follow-up of patients with NF1.

1 March 2015 in Journal of Investigative Dermatology
Verified
Journal Article
Open access
PDF file
EUElina Uusitalo
Elina Uusitalo
JLJussi Leppävirta
Jussi Leppävirta
AKAnna Koffert
Anna Koffert
SSSakari Suominen
Sakari Suominen
JVJussi Vahtera
Jussi Vahtera
SPSirkku Peltonen
Sirkku Peltonen

1 March 1990 in Journal of Cell Biology
Verified
Journal Article
Open access
PDF file
HLH Larjava
H Larjava
JPJuha Peltonen
Juha Peltonen
SAS K Akiyama
S K Akiyama
SYS S Yamada
S S Yamada
HGH R Gralnick
H R Gralnick
KYK M Yamada
K M Yamada
We have examined the expression, localization, and function of beta 1 integrins on cultured human epidermal keratinocytes using polyclonal and monoclonal antibodies against the beta 1, alpha 2, alpha 3, and alpha 5 integrin subunits. The beta 1 polypeptide, common to all class 1 integrins, was localized primarily in areas of cell-cell contacts of cultured keratinocytes, as were alpha 2 and alpha 3 polypeptides, suggesting a possible role in cell-cell adhesion for these integrin polypeptides. In contrast, the fibronectin receptor alpha 5 subunit showed no such accumulations in regions of cell-cell contact but was more diffusely distributed in the keratinocyte plasma membrane, consistent with the absence of fibronectin at cell-cell contact sites. Colonies of cultured keratinocytes could be dissociated by treatment with monoclonal antibody specific to the beta 1 polypeptide. Such dissociation of cell-cell contacts also occurred under conditions where the monoclonal antibody had no effect on cell-substrate adhesion. Therefore, beta 1 integrin-dependent cell-cell adhesion can be inhibited without affecting other cell-adhesive interactions. Antibody treatment of keratinocytes maintained in either low (0.15 mM) or high (1.2 mM) CaCl2 also resulted in the loss of organization of intracellular F-actin filaments and beta 1 integrins, even when the anti-beta 1 monoclonal antibody had no dissociating effect on keratinocyte colonies at the higher calcium concentration. Our results indicate that beta 1 integrins play roles in the maintenance of cell-cell contacts between keratinocytes and in the organization of intracellular microfilaments. They suggest that in epithelial cells integrins can function in cell-cell interactions as well as in cell-substrate adhesion.

1 April 2006 in Cancer Letters
Verified
Journal Article
Closed access
JKJussi Koivunen
Jussi Koivunen
VAVesa Aaltonen
Vesa Aaltonen
JPJuha Peltonen
Juha Peltonen

1 August 1991 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
JPJuha Peltonen
Juha Peltonen
LHLi Li Hsiao
Li Li Hsiao
SJSirkku Jaakkola
Sirkku Jaakkola
SSStephan Sollberg
Stephan Sollberg
MAMonique Aumailley
Monique Aumailley
JUJouni Uitto
Jouni Uitto

1 December 1989 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
JPJuha Peltonen
Juha Peltonen
HLH Larjava
H Larjava
SJS Jaakkola
S Jaakkola
HGH Gralnick
H Gralnick
SAS K Akiyama
S K Akiyama
JUJ Uitto
J Uitto
VLA integrins in human skin were examined by indirect immunofluorescence utilizing antibodies recognizing the beta 1, alpha 2, alpha 3, or alpha 5 subunits. Staining of fetal, newborn, or adult skin with antibodies to beta 1, alpha 2, or alpha 3 subunits gave essentially similar staining patterns: intense staining was associated with the basal layer of the epidermis, hair follicles, and blood vessel walls. The alpha 5 subunit could be detected only in epidermis and the inner root sheath of hair follicles in fetal skin. In epidermis, the staining reaction for the beta 1 subunit was not only found in sites interfacing with the basement membrane zone, but also around the entire periphery of these cells. We speculate that these receptors might have previously unrecognized functions in cell-cell interactions or that these findings may suggest the presence of previously unrecognized ligands in the intercellular spaces of keratinocytes. Examination of nine nodular basal cell carcinomas revealed a prominent staining reaction with anti-beta 1 and anti-alpha 3 antibodies at the periphery of the tumor islands. In contrast, staining of five squamous cell carcinomas revealed either the absence of integrins or altered and variable expression. Thus, matrix components and their receptors may participate in modulation of growth, development, and organization of human skin.